▶ 調査レポート

世界のNGSシーケンサー市場2023年:企業・地域・種類・用途別分析

• 英文タイトル:Global NGS Sequencers Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のNGSシーケンサー市場2023年:企業・地域・種類・用途別分析 / Global NGS Sequencers Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029 / MRC309Z7389資料のイメージです。• レポートコード:MRC309Z7389
• 出版社/出版日:GlobalInfoResearch / 2023年9月
• レポート形態:英文、PDF、113ページ
• 納品方法:Eメール(2-3営業日)
• 産業分類:医療機器&消耗品
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
GlobalInfoResearchの最新の調査によると、世界のNGSシーケンサーの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のNGSシーケンサー市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- NGSシーケンサーの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

NGSシーケンサー市場は種類と用途によって区分されます。2018年~2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・可逆的終端シーケンス、半導体シーケンス、複合プローブアンカー重合シーケンス

用途別セグメント
・病院&診療所、学術&研究機関、製薬&バイオテクノロジー企業、その他

主要な市場プレーヤー
・Illumina Inc.、BioMérieux、Life Technologies Corporation、Thermo Fisher Scientific、Memorial Sloan Kettering、BGI、PacBio、Agilent Technologies、Gene、Roche、Beckman Coulter、PerkinElmer、GTH.O、Boao Bio Group、Oxford Nanopore Technologies

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、NGSシーケンサー製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なNGSシーケンサーメーカーの企業概要、2019年~2022年までのNGSシーケンサーの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なNGSシーケンサーメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別NGSシーケンサーの販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までのNGSシーケンサーの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域でのNGSシーケンサー市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびNGSシーケンサーの産業チェーンを掲載しています。
・第14、15章では、NGSシーケンサーの販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
- NGSシーケンサーの概要
- 種類別分析(2018年vs2022年vs2029年):可逆的終端シーケンス、半導体シーケンス、複合プローブアンカー重合シーケンス
- 用途別分析(2018年vs2022年vs2029年):病院&診療所、学術&研究機関、製薬&バイオテクノロジー企業、その他
- 世界のNGSシーケンサー市場規模・予測
- 世界のNGSシーケンサー生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Illumina Inc.、BioMérieux、Life Technologies Corporation、Thermo Fisher Scientific、Memorial Sloan Kettering、BGI、PacBio、Agilent Technologies、Gene、Roche、Beckman Coulter、PerkinElmer、GTH.O、Boao Bio Group、Oxford Nanopore Technologies
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年:可逆的終端シーケンス、半導体シーケンス、複合プローブアンカー重合シーケンス
・用途別分析2018年-2029年:病院&診療所、学術&研究機関、製薬&バイオテクノロジー企業、その他
・NGSシーケンサーの北米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・NGSシーケンサーのヨーロッパ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・NGSシーケンサーのアジア市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・NGSシーケンサーの南米市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・NGSシーケンサーの中東・アフリカ市場
- 種類別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

According to our (Global Info Research) latest study, the global NGS Sequencers market size was valued at USD 902.4 million in 2022 and is forecast to a readjusted size of USD 2446.3 million by 2029 with a CAGR of 15.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
NGS sequencer is a massively parallel sequencing technology that can perform sequencing with ultra-high throughput, ultra-strong scalability, and ultra-fast speed. This technique is used to determine the order of nucleotides throughout the genome or in targeted regions of DNA or RNA.
This report is a detailed and comprehensive analysis for global NGS Sequencers market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global NGS Sequencers market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global NGS Sequencers market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global NGS Sequencers market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global NGS Sequencers market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for NGS Sequencers
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global NGS Sequencers market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina Inc., BioMérieux, Life Technologies Corporation, Thermo Fisher Scientific and Memorial Sloan Kettering, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
NGS Sequencers market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Reversible End Termination Sequencing
Semiconductor Sequencing
Combined Probe Anchored Polymerization Sequencing
Market segment by Application
Hospitals and Clinics
Academic and Research Institutions
Pharmaceutical and Biotech Companies
Other
Major players covered
Illumina Inc.
BioMérieux
Life Technologies Corporation
Thermo Fisher Scientific
Memorial Sloan Kettering
BGI
PacBio
Agilent Technologies
Gene
Roche
Beckman Coulter
PerkinElmer
GTH.O
Boao Bio Group
Oxford Nanopore Technologies
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe NGS Sequencers product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of NGS Sequencers, with price, sales, revenue and global market share of NGS Sequencers from 2018 to 2023.
Chapter 3, the NGS Sequencers competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the NGS Sequencers breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and NGS Sequencers market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of NGS Sequencers.
Chapter 14 and 15, to describe NGS Sequencers sales channel, distributors, customers, research findings and conclusion.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of NGS Sequencers
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global NGS Sequencers Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Reversible End Termination Sequencing
1.3.3 Semiconductor Sequencing
1.3.4 Combined Probe Anchored Polymerization Sequencing
1.4 Market Analysis by Application
1.4.1 Overview: Global NGS Sequencers Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals and Clinics
1.4.3 Academic and Research Institutions
1.4.4 Pharmaceutical and Biotech Companies
1.4.5 Other
1.5 Global NGS Sequencers Market Size & Forecast
1.5.1 Global NGS Sequencers Consumption Value (2018 & 2022 & 2029)
1.5.2 Global NGS Sequencers Sales Quantity (2018-2029)
1.5.3 Global NGS Sequencers Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Illumina Inc.
2.1.1 Illumina Inc. Details
2.1.2 Illumina Inc. Major Business
2.1.3 Illumina Inc. NGS Sequencers Product and Services
2.1.4 Illumina Inc. NGS Sequencers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Illumina Inc. Recent Developments/Updates
2.2 BioMérieux
2.2.1 BioMérieux Details
2.2.2 BioMérieux Major Business
2.2.3 BioMérieux NGS Sequencers Product and Services
2.2.4 BioMérieux NGS Sequencers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BioMérieux Recent Developments/Updates
2.3 Life Technologies Corporation
2.3.1 Life Technologies Corporation Details
2.3.2 Life Technologies Corporation Major Business
2.3.3 Life Technologies Corporation NGS Sequencers Product and Services
2.3.4 Life Technologies Corporation NGS Sequencers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Life Technologies Corporation Recent Developments/Updates
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific NGS Sequencers Product and Services
2.4.4 Thermo Fisher Scientific NGS Sequencers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Recent Developments/Updates
2.5 Memorial Sloan Kettering
2.5.1 Memorial Sloan Kettering Details
2.5.2 Memorial Sloan Kettering Major Business
2.5.3 Memorial Sloan Kettering NGS Sequencers Product and Services
2.5.4 Memorial Sloan Kettering NGS Sequencers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Memorial Sloan Kettering Recent Developments/Updates
2.6 BGI
2.6.1 BGI Details
2.6.2 BGI Major Business
2.6.3 BGI NGS Sequencers Product and Services
2.6.4 BGI NGS Sequencers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 BGI Recent Developments/Updates
2.7 PacBio
2.7.1 PacBio Details
2.7.2 PacBio Major Business
2.7.3 PacBio NGS Sequencers Product and Services
2.7.4 PacBio NGS Sequencers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 PacBio Recent Developments/Updates
2.8 Agilent Technologies
2.8.1 Agilent Technologies Details
2.8.2 Agilent Technologies Major Business
2.8.3 Agilent Technologies NGS Sequencers Product and Services
2.8.4 Agilent Technologies NGS Sequencers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Agilent Technologies Recent Developments/Updates
2.9 Gene
2.9.1 Gene Details
2.9.2 Gene Major Business
2.9.3 Gene NGS Sequencers Product and Services
2.9.4 Gene NGS Sequencers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Gene Recent Developments/Updates
2.10 Roche
2.10.1 Roche Details
2.10.2 Roche Major Business
2.10.3 Roche NGS Sequencers Product and Services
2.10.4 Roche NGS Sequencers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Roche Recent Developments/Updates
2.11 Beckman Coulter
2.11.1 Beckman Coulter Details
2.11.2 Beckman Coulter Major Business
2.11.3 Beckman Coulter NGS Sequencers Product and Services
2.11.4 Beckman Coulter NGS Sequencers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Beckman Coulter Recent Developments/Updates
2.12 PerkinElmer
2.12.1 PerkinElmer Details
2.12.2 PerkinElmer Major Business
2.12.3 PerkinElmer NGS Sequencers Product and Services
2.12.4 PerkinElmer NGS Sequencers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 PerkinElmer Recent Developments/Updates
2.13 GTH.O
2.13.1 GTH.O Details
2.13.2 GTH.O Major Business
2.13.3 GTH.O NGS Sequencers Product and Services
2.13.4 GTH.O NGS Sequencers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 GTH.O Recent Developments/Updates
2.14 Boao Bio Group
2.14.1 Boao Bio Group Details
2.14.2 Boao Bio Group Major Business
2.14.3 Boao Bio Group NGS Sequencers Product and Services
2.14.4 Boao Bio Group NGS Sequencers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Boao Bio Group Recent Developments/Updates
2.15 Oxford Nanopore Technologies
2.15.1 Oxford Nanopore Technologies Details
2.15.2 Oxford Nanopore Technologies Major Business
2.15.3 Oxford Nanopore Technologies NGS Sequencers Product and Services
2.15.4 Oxford Nanopore Technologies NGS Sequencers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Oxford Nanopore Technologies Recent Developments/Updates
3 Competitive Environment: NGS Sequencers by Manufacturer
3.1 Global NGS Sequencers Sales Quantity by Manufacturer (2018-2023)
3.2 Global NGS Sequencers Revenue by Manufacturer (2018-2023)
3.3 Global NGS Sequencers Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of NGS Sequencers by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 NGS Sequencers Manufacturer Market Share in 2022
3.4.2 Top 6 NGS Sequencers Manufacturer Market Share in 2022
3.5 NGS Sequencers Market: Overall Company Footprint Analysis
3.5.1 NGS Sequencers Market: Region Footprint
3.5.2 NGS Sequencers Market: Company Product Type Footprint
3.5.3 NGS Sequencers Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global NGS Sequencers Market Size by Region
4.1.1 Global NGS Sequencers Sales Quantity by Region (2018-2029)
4.1.2 Global NGS Sequencers Consumption Value by Region (2018-2029)
4.1.3 Global NGS Sequencers Average Price by Region (2018-2029)
4.2 North America NGS Sequencers Consumption Value (2018-2029)
4.3 Europe NGS Sequencers Consumption Value (2018-2029)
4.4 Asia-Pacific NGS Sequencers Consumption Value (2018-2029)
4.5 South America NGS Sequencers Consumption Value (2018-2029)
4.6 Middle East and Africa NGS Sequencers Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global NGS Sequencers Sales Quantity by Type (2018-2029)
5.2 Global NGS Sequencers Consumption Value by Type (2018-2029)
5.3 Global NGS Sequencers Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global NGS Sequencers Sales Quantity by Application (2018-2029)
6.2 Global NGS Sequencers Consumption Value by Application (2018-2029)
6.3 Global NGS Sequencers Average Price by Application (2018-2029)
7 North America
7.1 North America NGS Sequencers Sales Quantity by Type (2018-2029)
7.2 North America NGS Sequencers Sales Quantity by Application (2018-2029)
7.3 North America NGS Sequencers Market Size by Country
7.3.1 North America NGS Sequencers Sales Quantity by Country (2018-2029)
7.3.2 North America NGS Sequencers Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe NGS Sequencers Sales Quantity by Type (2018-2029)
8.2 Europe NGS Sequencers Sales Quantity by Application (2018-2029)
8.3 Europe NGS Sequencers Market Size by Country
8.3.1 Europe NGS Sequencers Sales Quantity by Country (2018-2029)
8.3.2 Europe NGS Sequencers Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific NGS Sequencers Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific NGS Sequencers Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific NGS Sequencers Market Size by Region
9.3.1 Asia-Pacific NGS Sequencers Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific NGS Sequencers Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America NGS Sequencers Sales Quantity by Type (2018-2029)
10.2 South America NGS Sequencers Sales Quantity by Application (2018-2029)
10.3 South America NGS Sequencers Market Size by Country
10.3.1 South America NGS Sequencers Sales Quantity by Country (2018-2029)
10.3.2 South America NGS Sequencers Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa NGS Sequencers Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa NGS Sequencers Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa NGS Sequencers Market Size by Country
11.3.1 Middle East & Africa NGS Sequencers Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa NGS Sequencers Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 NGS Sequencers Market Drivers
12.2 NGS Sequencers Market Restraints
12.3 NGS Sequencers Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of NGS Sequencers and Key Manufacturers
13.2 Manufacturing Costs Percentage of NGS Sequencers
13.3 NGS Sequencers Production Process
13.4 NGS Sequencers Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 NGS Sequencers Typical Distributors
14.3 NGS Sequencers Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer